LU77764A1 - - Google Patents

Info

Publication number
LU77764A1
LU77764A1 LU77764A LU77764A LU77764A1 LU 77764 A1 LU77764 A1 LU 77764A1 LU 77764 A LU77764 A LU 77764A LU 77764 A LU77764 A LU 77764A LU 77764 A1 LU77764 A1 LU 77764A1
Authority
LU
Luxembourg
Application number
LU77764A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU77764A1 publication Critical patent/LU77764A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
LU77764A 1976-07-16 1977-07-14 LU77764A1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
LU77764A1 true LU77764A1 (cg-RX-API-DMAC10.html) 1978-02-02

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
LU77764A LU77764A1 (cg-RX-API-DMAC10.html) 1976-07-16 1977-07-14

Country Status (29)

Country Link
US (1) US4080454A (cg-RX-API-DMAC10.html)
JP (1) JPS5337673A (cg-RX-API-DMAC10.html)
AR (1) AR213652A1 (cg-RX-API-DMAC10.html)
AT (1) AT351561B (cg-RX-API-DMAC10.html)
BE (1) BE856710A (cg-RX-API-DMAC10.html)
CA (1) CA1061788A (cg-RX-API-DMAC10.html)
CH (1) CH622512A5 (cg-RX-API-DMAC10.html)
CS (1) CS212264B2 (cg-RX-API-DMAC10.html)
DD (1) DD131556A5 (cg-RX-API-DMAC10.html)
DE (1) DE2731736A1 (cg-RX-API-DMAC10.html)
DK (1) DK139029B (cg-RX-API-DMAC10.html)
EG (1) EG12762A (cg-RX-API-DMAC10.html)
ES (1) ES460686A1 (cg-RX-API-DMAC10.html)
FI (1) FI772183A7 (cg-RX-API-DMAC10.html)
FR (1) FR2358399A1 (cg-RX-API-DMAC10.html)
GB (1) GB1542178A (cg-RX-API-DMAC10.html)
GR (1) GR68686B (cg-RX-API-DMAC10.html)
HU (1) HU177713B (cg-RX-API-DMAC10.html)
IL (1) IL52409A (cg-RX-API-DMAC10.html)
LU (1) LU77764A1 (cg-RX-API-DMAC10.html)
NL (1) NL7707729A (cg-RX-API-DMAC10.html)
NO (1) NO772489L (cg-RX-API-DMAC10.html)
PH (1) PH13190A (cg-RX-API-DMAC10.html)
PL (1) PL103783B1 (cg-RX-API-DMAC10.html)
PT (1) PT66808B (cg-RX-API-DMAC10.html)
SE (1) SE421125B (cg-RX-API-DMAC10.html)
SU (1) SU673169A3 (cg-RX-API-DMAC10.html)
YU (1) YU171677A (cg-RX-API-DMAC10.html)
ZA (1) ZA773927B (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
KR101452518B1 (ko) * 2005-08-22 2014-10-21 멜리어 파마슈티칼스 아이, 인코포레이티드 Lyn 키나제 활성의 조절 및 관련된 장애의 치료를 위한방법 및 제제
EP2120581A4 (en) * 2007-02-20 2011-03-16 Melior Pharmaceuticals I Inc METHODS OF IDENTIFYING LYN KINASE ACTIVATORS
EP2180894A4 (en) * 2007-07-23 2012-08-29 Melior Pharmaceuticals I Inc METHOD OF ACTIVATING IRS-1 AND ACT
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) * 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
EP3609500B1 (en) 2017-04-10 2024-11-13 Melior Pharmaceuticals I, Inc. Treatment of adipocytes
CA3088178A1 (en) 2018-02-21 2019-08-29 Melior Pharmaceuticals I, Inc. Treatment of liver diseases
WO2026125941A1 (en) 2024-12-13 2026-06-18 Biodexa Ltd. Lyn kinase activators for use in treating fibrosis or diseases associated with fibrosis

Also Published As

Publication number Publication date
PH13190A (en) 1980-01-16
US4080454A (en) 1978-03-21
BE856710A (fr) 1978-01-11
GB1542178A (en) 1979-03-14
SE7707471L (sv) 1978-01-17
DK318177A (cg-RX-API-DMAC10.html) 1978-01-17
JPS5337673A (en) 1978-04-06
SE421125B (sv) 1981-11-30
SU673169A3 (ru) 1979-07-05
JPS5512017B2 (cg-RX-API-DMAC10.html) 1980-03-29
AR213652A1 (es) 1979-02-28
GR68686B (cg-RX-API-DMAC10.html) 1982-02-01
NL7707729A (nl) 1978-01-18
AT351561B (de) 1979-08-10
DD131556A5 (de) 1978-07-05
PL103783B1 (pl) 1979-07-31
IL52409A (en) 1979-11-30
HU177713B (en) 1981-12-28
FR2358399B1 (cg-RX-API-DMAC10.html) 1980-10-17
NO772489L (no) 1978-01-17
CH622512A5 (cg-RX-API-DMAC10.html) 1981-04-15
CS212264B2 (en) 1982-03-26
YU171677A (en) 1982-06-30
EG12762A (en) 1979-12-31
IL52409A0 (en) 1977-08-31
DK139029C (cg-RX-API-DMAC10.html) 1979-05-07
AU2663877A (en) 1978-05-18
PT66808A (en) 1977-08-01
ES460686A1 (es) 1978-12-01
FI772183A7 (cg-RX-API-DMAC10.html) 1978-01-17
ZA773927B (en) 1978-05-30
PT66808B (en) 1978-12-21
DE2731736A1 (de) 1978-01-26
CA1061788A (en) 1979-09-04
PL199633A1 (pl) 1978-04-10
FR2358399A1 (fr) 1978-02-10
DK139029B (da) 1978-12-04
ATA509277A (de) 1979-01-15

Similar Documents

Publication Publication Date Title
FI770229A7 (cg-RX-API-DMAC10.html)
FR2358399B1 (cg-RX-API-DMAC10.html)
JPS535334U (cg-RX-API-DMAC10.html)
JPS5745009B2 (cg-RX-API-DMAC10.html)
JPS562800Y2 (cg-RX-API-DMAC10.html)
JPS52105164U (cg-RX-API-DMAC10.html)
FR2375965B1 (cg-RX-API-DMAC10.html)
JPS5613054B2 (cg-RX-API-DMAC10.html)
JPS52157714U (cg-RX-API-DMAC10.html)
CS178362B1 (cg-RX-API-DMAC10.html)
JPS5337082U (cg-RX-API-DMAC10.html)
JPS5318240U (cg-RX-API-DMAC10.html)
JPS5322483U (cg-RX-API-DMAC10.html)
JPS52160385U (cg-RX-API-DMAC10.html)
JPS536448U (cg-RX-API-DMAC10.html)
DD124199A1 (cg-RX-API-DMAC10.html)
DD124817A1 (cg-RX-API-DMAC10.html)
DD124158A1 (cg-RX-API-DMAC10.html)
CH609792A5 (cg-RX-API-DMAC10.html)
DD124633A1 (cg-RX-API-DMAC10.html)
CH606668A5 (cg-RX-API-DMAC10.html)
CH593248A5 (cg-RX-API-DMAC10.html)
CH611458A5 (cg-RX-API-DMAC10.html)
DD123808A1 (cg-RX-API-DMAC10.html)
CH609904A5 (cg-RX-API-DMAC10.html)